This invention is based on the discovery that Interleukin-4 (IL-4) greatly enhances macrophage mannose receptor activity. The invention provides use of IL-4 or an IL-4 antagonist or IL-4 receptor blocking agent in the treatment of human or animal patients suffering from infections involving mannosylated pathogens.
